Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel tetrahydrochinoline derived CETP inhibitors.
Schmeck C, Gielen-Haertwig H, Vakalopoulos A, Bischoff H, Li V, Wirtz G, Weber O. Schmeck C, et al. Among authors: bischoff h. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1740-3. doi: 10.1016/j.bmcl.2010.01.071. Epub 2010 Jan 21. Bioorg Med Chem Lett. 2010. PMID: 20137927
Novel heterocyclic thyromimetics. Part 2.
Haning H, Mueller U, Schmidt G, Schmeck C, Voehringer V, Kretschmer A, Bischoff H. Haning H, et al. Among authors: bischoff h. Bioorg Med Chem Lett. 2007 Jul 15;17(14):3992-6. doi: 10.1016/j.bmcl.2007.04.085. Epub 2007 Apr 29. Bioorg Med Chem Lett. 2007. PMID: 17499989
Cholesteryl ester transfer protein and its inhibition.
Weber O, Bischoff H, Schmeck C, Böttcher MF. Weber O, et al. Among authors: bischoff h. Cell Mol Life Sci. 2010 Sep;67(18):3139-49. doi: 10.1007/s00018-010-0418-3. Epub 2010 Jun 18. Cell Mol Life Sci. 2010. PMID: 20556633 Review.
Chromanol derivatives--a novel class of CETP inhibitors.
Vakalopoulos A, Schmeck C, Thutewohl M, Li V, Bischoff H, Lustig K, Weber O, Paulsen H, Elias H. Vakalopoulos A, et al. Among authors: bischoff h. Bioorg Med Chem Lett. 2011 Jan 1;21(1):488-91. doi: 10.1016/j.bmcl.2010.10.110. Epub 2010 Oct 26. Bioorg Med Chem Lett. 2011. PMID: 21084191
Prediction of a potentially effective dose in humans for BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein (CETP) by allometric species scaling and combined pharmacodynamic and physiologically-based pharmacokinetic modelling.
Weber O, Willmann S, Bischoff H, Li V, Vakalopoulos A, Lustig K, Hafner FT, Heinig R, Schmeck C, Buehner K. Weber O, et al. Among authors: bischoff h. Br J Clin Pharmacol. 2012 Feb;73(2):219-31. doi: 10.1111/j.1365-2125.2011.04064.x. Br J Clin Pharmacol. 2012. PMID: 21762205 Free PMC article.
Glycine amides as PPARalpha agonists.
Urbahns K, Woltering M, Nikolic S, Pernerstorfer J, Bischoff H, Dittrich-Wengenroth E, Lustig K. Urbahns K, et al. Among authors: bischoff h. Bioorg Med Chem Lett. 2010 Jun 1;20(11):3376-9. doi: 10.1016/j.bmcl.2010.04.019. Epub 2010 Apr 13. Bioorg Med Chem Lett. 2010. PMID: 20452212
191 results